Announcements Trials
Browse Landscape

Phase

Phase NA 4Phase 1 1

Status

Completed 3Terminated 1Recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 13Other hematologic neoplasm 12Gynecologic 10Genitourinary 7Plasma cell 6Tumor-Agnostic 5Thoracic 5Other solid neoplasm 5Gastrointestinal 5Lymphoid 4Head & Neck 4Myeloid 3Other 2CNS 2Other neoplasm 1

Conditions

Neoplasms 4Neoplasm Metastasis 1

Interventions

pembrolizumab 94Paclitaxel 85Gemcitabine 83Carboplatin 79Docetaxel 60Cisplatin 58Bevacizumab 58Nivolumab 56Fluorouracil 47Capecitabine 46Magnetic Resonance Spectroscopy 44Radiotherapy 41Irinotecan 40Oxaliplatin 38Erlotinib Hydrochloride 37Pemetrexed 34Leucovorin 34Biopsy 34atezolizumab 33Cetuximab 32Standard of Care 31Trastuzumab 28Cyclophosphamide 28Blood Specimen Collection 28Radiosurgery 27Specimen Handling 26Sorafenib 26Ipilimumab 26Everolimus 26olaparib 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Behavior Therapy × Tumor-Agnostic × Clear all
NCT06434402 2026-01-20

A Virtual, Group-Based, Expressive Writing Intervention for Survivors of Adolescent and Young Adult Cancer

M.D. Anderson Cancer Center

Phase NA Recruiting
30 enrolled
Tumor-Agnostic

Neoplasms

NCT06644170 2025-10-14

A Second Psilocybin Group Therapy for the Treatment of Cancer-Related Anxiety in Partial Responders With Metastatic Cancer

University of Washington

Phase 1 Completed
15 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT06796608 2025-05-07

BALANCE

University of Pittsburgh

Phase NA Completed
22 enrolled
Tumor-Agnostic

Neoplasms

NCT03979794 2024-11-14

A Distress Screening and Intervention in Cancer Surgery

Baylor College of Medicine

Phase NA Terminated
16 enrolled
Tumor-Agnostic

Neoplasms

NCT01576107 2014-04-23

MOTIVACTION - Study

German Cancer Research Center

Phase NA Completed
76 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡